Did the U.S. Food and Drug Administration act illegally, capriciously and arbitrarily in its treatment of imported orange juice during the carbendazim incident? 

This is the question that FDAImports.com Principal, Rick Quinn, and Associate Attorney, John Johnson, answer in their recent article published in the Food and Drug Law Institute’s Update magazine.  The article, “Imported Orange Juice Gets the Squeeze: FDA’s Illegal Treatment of Brazilian Orange Juice During the Carbendazim Incident,” clearly outlines the history of the carbendazim issue, the FDA’s inconsistent response to both domestic and foreign juices, … READ MORE

Share

In February 2012, news of fake Avastin in the United States hit the news wires.  Cancer patients were being administered water while under the impression that it was the actual cancer treatment drug, Avastin.  People were outraged.  Weeks later, another shipment of the counterfeit drug was discovered in the United States.  “What’s being done about this?” was the outcry from the press.  Shortly thereafter, the Senate passed the Counterfeit Drug Penalty Enhancement Act of 2011,1 a bill that had been sitting in committee … READ MORE

Share

The www.FDAImports.com, LLC expert team of FDA consultants and FDA attorneys obtained removal of another client processor from another FDA Import Alert, this time, Import Alert #72-03, “Detention without Physical Examination and Intensified Coverage of Pig Ears and other Pet Treats Due to the Presence of Salmonella.”

A 2004 FDA examination and sampling found Salmonella in untreated rawhide scraps. FDA placed the Mexican processor on the Import Alert Red List. That shipment was a one-time event, as the Mexican supplier was in the business of processing and shipping finished rawhide pet chews and treats – not unfinished rawhide scraps.   However, in … READ MORE

Share